sufentanil has been researched along with Substance Withdrawal Syndrome in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (8.33) | 18.7374 |
| 1990's | 5 (41.67) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benahmed-Canat, A; Canat, G; Claris, O; Kassai, B; Nguyen, KA; Paret, N; Plaisant, F; Rabilloud, M; Riche, B | 1 |
| Hronová, K; Pokorná, P; Posch, L; Slanař, O | 1 |
| Freye, E; Levy, JV | 1 |
| Chakrabarti, S; Gintzler, AR; Liu, NJ; Sharma, T; Zadina, JE | 1 |
| Freye, EC; Korak-Leiter, M; Levy, JV; Likar, R; Oher, M; Trampitsch, E; Ziervogel, G | 1 |
| Freye, E; Levy, J | 1 |
| Adams, RE; Wooten, GF | 2 |
| de Leon-Casasola, OA; Lema, MJ | 1 |
| Fassos, FF; Mucha, RF; Walker, MJ | 1 |
| Ayesta, FJ; Flórez, J | 1 |
| Stevens, CW; Yaksh, TL | 1 |
1 trial(s) available for sufentanil and Substance Withdrawal Syndrome
| Article | Year |
|---|---|
Withdrawal following sufentanil/propofol and sufentanil/midazolam. Sedation in surgical ICU patients: correlation with central nervous parameters and endogenous opioids.
Topics: Adolescent; Adult; Aged; Analgesics, Opioid; beta-Endorphin; Blood Pressure; Conscious Sedation; Critical Care; Delirium; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electroencephalography; Enkephalin, Methionine; Evoked Potentials, Somatosensory; Female; Heart Rate; Humans; Hypnotics and Sedatives; Male; Midazolam; Middle Aged; Postoperative Care; Propofol; Substance Withdrawal Syndrome; Sufentanil | 2005 |
11 other study(ies) available for sufentanil and Substance Withdrawal Syndrome
| Article | Year |
|---|---|
Postsurgery analgesic and sedative drug use in a French neonatal intensive care unit: A single-center retrospective cohort study.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Analgesics, Opioid; Cohort Studies; Drug Utilization; Female; Fentanyl; France; Hospitals, University; Humans; Hypnotics and Sedatives; Infant; Infant, Newborn; Intensive Care Units, Neonatal; Male; Midazolam; Morphine; Nalbuphine; Off-Label Use; Pain Measurement; Pain, Postoperative; Retrospective Studies; Substance Withdrawal Syndrome; Sufentanil; Urinary Retention | 2019 |
Sufentanil and midazolam dosing and pharmacogenetic factors in pediatric analgosedation and withdrawal syndrome.
Topics: Adjuvants, Anesthesia; Child; Dose-Response Relationship, Drug; Female; Genetic Variation; Humans; Infant; Infant, Newborn; Male; Midazolam; Pediatrics; Pharmacogenetics; Polymorphism, Single Nucleotide; Substance Withdrawal Syndrome; Sufentanil | 2016 |
No hyperalgesia following opioid withdrawal after the oripavine derivative etorphine compared to remifentanil and sufentanil.
Topics: Afferent Pathways; Analgesics, Opioid; Animals; Blood Pressure; Bradycardia; Dogs; Dose-Response Relationship, Drug; Etorphine; Evoked Potentials, Somatosensory; Heart Rate; Hyperalgesia; Hypotension; Naloxone; Narcotic Antagonists; Piperidines; Remifentanil; Substance Withdrawal Syndrome; Sufentanil | 2010 |
Pleiotropic opioid regulation of spinal endomorphin 2 release and its adaptations to opioid withdrawal are sexually dimorphic.
Topics: Adaptation, Physiological; Analgesics, Opioid; Animals; Blotting, Western; Cholera Toxin; Dose-Response Relationship, Drug; Endorphins; Female; Immunoprecipitation; Male; Morphine; Narcotic Antagonists; Oligopeptides; Perfusion; Pertussis Toxin; Protein Phosphatase 2; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Sex Characteristics; Spine; Substance Withdrawal Syndrome; Sufentanil | 2012 |
Constitutive opioid receptor activation: a prerequisite mechanism involved in acute opioid withdrawal.
Topics: Acute Disease; Animals; Biotransformation; Dogs; Evoked Potentials, Somatosensory; Naltrexone; Narcotics; Protein Kinase C; Receptors, Opioid; Somatoform Disorders; Substance Withdrawal Syndrome; Sufentanil | 2005 |
Regional cerebral glucose utilization in withdrawal following systemic and intracerebroventricular sufentanil administration.
Topics: Animals; Brain; Cerebral Ventricles; Glucose; Infusions, Intravenous; Infusions, Parenteral; Male; Morphine Dependence; Rats; Rats, Sprague-Dawley; Receptors, Opioid, mu; Substance Withdrawal Syndrome; Sufentanil | 1994 |
Is morphine dependence mediated exclusively by the Mu receptor?
Topics: Animals; Behavior, Animal; Brain; Glucose; Male; Morphine Dependence; Naloxone; Rats; Rats, Sprague-Dawley; Receptors, Opioid, mu; Regression Analysis; Substance Withdrawal Syndrome; Sufentanil | 1993 |
Epidural sufentanil for acute pain control in a patient with extreme opioid dependency.
Topics: Adult; Analgesia, Epidural; Analgesics; Female; Fentanyl; Humans; Methadone; Pain, Postoperative; Postoperative Complications; Substance Withdrawal Syndrome; Sufentanil | 1992 |
Parker and Radow test of drug withdrawal aversion: opposite effect in rats chronically infused with sufentanil or amphetamine.
Topics: Analgesics, Opioid; Animals; Body Weight; Choice Behavior; Dextroamphetamine; Fentanyl; Infusion Pumps; Male; Rats; Rats, Inbred Strains; Substance Withdrawal Syndrome; Sufentanil; Taste | 1990 |
Tolerance to the respiratory actions of opiates: withdrawal tolerance and asymmetrical cross-tolerance.
Topics: Animals; Dose-Response Relationship, Drug; Drug Tolerance; Enkephalin, Leucine; Enkephalin, Leucine-2-Alanine; Fentanyl; Injections, Intravenous; Injections, Intraventricular; Injections, Subcutaneous; Male; Morphine; Narcotics; Rats; Rats, Inbred Strains; Respiratory System; Substance Withdrawal Syndrome; Sufentanil | 1990 |
Magnitude of opioid dependence after continuous intrathecal infusion of mu- and delta-selective opioids in the rat.
Topics: Animals; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, Leucine; Enkephalin, Leucine-2-Alanine; Enkephalins; Fentanyl; Injections, Spinal; Male; Morphine; Naloxone; Narcotics; Rats; Rats, Inbred Strains; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, mu; Substance Withdrawal Syndrome; Substance-Related Disorders; Sufentanil; Time Factors | 1989 |